A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis ClinicalTrials.gov, 1 Jun 2015 Accessed on 30 Jun 2015 from http://clinicaltrials.gov/ct2/show/NCT01247324. CommentRecommendBookmarkWatch
